Literature DB >> 22672221

Progression of subclinical myocardial dysfunction in type 2 diabetes after 5 years despite improved glycemic control.

Vlad Damian Vintila1, Aled Roberts, Dragos Vinereanu, Alan Gordon Fraser.   

Abstract

BACKGROUND: Patients with uncomplicated diabetes have reduced left ventricular long-axis function, related to poor glycemic control and increased conduit arterial stiffness, with increased radial function. It is unknown if improved control of risk factors can reverse these subclinical changes. PATIENTS AND METHODS: We studied 27 patients with type 2 diabetes (18 men) 57 ± 1 months (mean ± SD) after an initial visit when they were compared with healthy age- and sex-matched controls. On both visits patients had detailed echocardiographic studies including tissue Doppler, noninvasive tests of conduit arterial function, and metabolic and lipid profiling.
RESULTS: Mean age at this second review was 63.4 ± 8.1 years; 48% of patients received insulin. Mean HbA1c had decreased by 13% to 8 ± 1.6% and cholesterol by 17% to 4.3 ± 1.3 mmol/L (both, P < 0.01), but long-axis systolic and early diastolic myocardial velocities had also declined, by 13% and 20%, respectively (both, P < 0.001). Body mass index had increased by 4%, arterial pulse pressure by 17% (both P < 0.01), and carotid arterial stiffness by 49% (P < 0.01). Fractional shortening (by 21%, P < 0.001), radial systolic velocity (by 13%, P < 0.05), and ejection fraction (by 9% to 68 ± 7%, P < 0.01) had all declined. Reductions in longitudinal function were best predicted by its baseline measurements, duration of diabetes, fasting triglycerides, and arterial stiffness (epsilon index).
CONCLUSIONS: Despite improved diabetic control, subclinical left ventricular dysfunction progressed over 5 years. Radial compensation was reversed. Prevention of subclinical myocardial dysfunction in diabetes might require more intensive control of net cardiovascular risk.
© 2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22672221     DOI: 10.1111/j.1540-8175.2012.01748.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  7 in total

Review 1.  New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes.

Authors:  Michele Senni; Walter J Paulus; Antonello Gavazzi; Alan G Fraser; Javier Díez; Scott D Solomon; Otto A Smiseth; Marco Guazzi; Carolyn S P Lam; Aldo P Maggioni; Carsten Tschöpe; Marco Metra; Scott L Hummel; Frank Edelmann; Giuseppe Ambrosio; Andrew J Stewart Coats; Gerasimos S Filippatos; Mihai Gheorghiade; Stefan D Anker; Daniel Levy; Marc A Pfeffer; Wendy Gattis Stough; Burkert M Pieske
Journal:  Eur Heart J       Date:  2014-08-07       Impact factor: 29.983

Review 2.  [Echocardiography in diabetic cardiomyopathy].

Authors:  M Niemann; S Herrmann; G Ertl; F Weidemann
Journal:  Herz       Date:  2012-11-29       Impact factor: 1.443

Review 3.  The heart failure burden of type 2 diabetes mellitus-a review of pathophysiology and interventions.

Authors:  Anne Pernille Ofstad; Dan Atar; Lars Gullestad; Gisle Langslet; Odd Erik Johansen
Journal:  Heart Fail Rev       Date:  2018-05       Impact factor: 4.214

4.  Presystolic Wave is Associated with Subclinical Left Ventricular Dysfunction Assessed by Myocardial Performance Index in Type 2 Diabetes Mellitus.

Authors:  Selim Kul; İhsan Dursun; Semiha Ayhan; Muhammet Rasit Sayin; Özge Üçüncü; Nilgün Esen Bülbül; Ahmet Hakan Ateş; Ali Rıza Akyüz
Journal:  Arq Bras Cardiol       Date:  2019-07-29       Impact factor: 2.000

5.  Nomogram based on multimodal echocardiography for assessing the evolution of diabetic cardiomyopathy in diabetic patients with normal cardiac function.

Authors:  Yi Liu; Hao Lu; Yan Zhang; Mengjie Cai; Jia Guo; Xiaofen Ruan
Journal:  Front Cardiovasc Med       Date:  2022-09-20

6.  The activity of circulating dipeptidyl peptidase-4 is associated with subclinical left ventricular dysfunction in patients with type 2 diabetes mellitus.

Authors:  Susana Ravassa; Joaquín Barba; Isabel Coma-Canella; Ana Huerta; Begoña López; Arantxa González; Javier Díez
Journal:  Cardiovasc Diabetol       Date:  2013-10-07       Impact factor: 9.951

7.  The additive effects of type 2 diabetes mellitus on left ventricular deformation and myocardial perfusion in essential hypertension: a 3.0 T cardiac magnetic resonance study.

Authors:  Xue-Ming Li; Li Jiang; Ying-Kun Guo; Yan Ren; Pei-Lun Han; Li-Qing Peng; Rui Shi; Wei-Feng Yan; Zhi-Gang Yang
Journal:  Cardiovasc Diabetol       Date:  2020-09-30       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.